Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice.

Gilchuk IM, Bangaru S, Gilchuk P, Irving RP, Kose N, Bombardi RG, Thornburg NJ, Creech CB, Edwards KM, Li S, Turner HL, Yu W, Zhu X, Wilson IA, Ward AB, Crowe JE Jr.

Cell Host Microbe. 2019 Nov 1. pii: S1931-3128(19)30527-X. doi: 10.1016/j.chom.2019.10.003. [Epub ahead of print]

PMID:
31757769
2.

Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents.

Munoz FM, Anderson EJ, Bernstein DI, Harrison CJ, Pahud B, Anderson E, Creech CB, Berry AA, Kotloff KL, Walter EB, Atmar RL, Bellamy AR, Chang S, Keitel WA.

Vaccine. 2019 Aug 23;37(36):5161-5170. doi: 10.1016/j.vaccine.2019.07.085. Epub 2019 Jul 30.

PMID:
31375440
3.

Effect of Concomitant Antibiotic and Vaccine Administration on Serologic Responses to Rotavirus Vaccine.

Anderson EJ, Lopman B, Yi J, Libster R, Creech CB, El-Khorazaty J, Baqar S, Yildirim I, Kao C, Rouphael N, Shane AL, Edwards K.

J Pediatric Infect Dis Soc. 2019 Jun 25. pii: piz044. doi: 10.1093/jpids/piz044. [Epub ahead of print]

PMID:
31237948
4.

The Emperor's New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE).

Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, Bleasdale SC, Schultz S, Barron M, Stapleton A, Wray D, Chambers H, Fowler V, Holland TL; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2019 Jun 3. pii: ciz460. doi: 10.1093/cid/ciz460. [Epub ahead of print]

PMID:
31157370
5.

Molecular Epidemiology of Invasive Staphylococcus aureus Infections and Concordance with Colonization Isolates.

Thomsen IP, Kadari P, Soper NR, Riddell S, Kiska D, Creech CB, Shaw J.

J Pediatr. 2019 Jul;210:173-177. doi: 10.1016/j.jpeds.2019.03.004. Epub 2019 Apr 5.

PMID:
30961989
6.

Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States.

Mohamed N, Timofeyeva Y, Jamrozy D, Rojas E, Hao L, Silmon de Monerri NC, Hawkins J, Singh G, Cai B, Liberator P, Sebastian S, Donald RGK, Scully IL, Jones CH, Creech CB, Thomsen I, Parkhill J, Peacock SJ, Jansen KU, Holden MTG, Anderson AS.

PLoS One. 2019 Jan 14;14(1):e0208356. doi: 10.1371/journal.pone.0208356. eCollection 2019.

7.

Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units.

Kotloff KL, Shirley DT, Creech CB, Frey SE, Harrison CJ, Staat M, Anderson EJ, Dulkerian S, Thomsen IP, Al-Hosni M, Pahud BA, Bernstein DI, Yi J, Petrikin JE, Haberman B, Stephens K, Stephens I, Oler RE Jr, Conrad TM.

Pediatrics. 2019 Jan;143(1). pii: e20181565. doi: 10.1542/peds.2018-1565.

PMID:
30587533
8.

AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells.

Howard LM, Goll JB, Jensen TL, Hoek KL, Prasad N, Gelber CE, Levy SE, Joyce S, Link AJ, Creech CB, Edwards KM.

J Infect Dis. 2019 May 5;219(11):1786-1798. doi: 10.1093/infdis/jiy721.

PMID:
30566602
9.

Advances in pediatric antimicrobial agents development.

Wood JB, Cravens LB, Creech CB.

Curr Opin Pediatr. 2019 Feb;31(1):135-143. doi: 10.1097/MOP.0000000000000713.

PMID:
30507647
10.

Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist Workforce.

Singh U, Levy J, Armstrong W, Bedimo R, Creech CB, Lautenbach E, Popovich KJ, Snowden J, Vyas JM; Infectious Diseases Society of America, HIV Medicine Association, and Pediatric Infectious Diseases Society.

J Infect Dis. 2018 Aug 14;218(suppl_1):S49-S54. doi: 10.1093/infdis/jiy246.

PMID:
30124981
11.

Performance of TEM-PCR vs Culture for Bacterial Identification in Pediatric Musculoskeletal Infections.

Wood JB, Sesler C, Stalons D, Grigorenko E, Schoenecker JG, Creech CB, Thomsen IP.

Open Forum Infect Dis. 2018 May 22;5(6):ofy119. doi: 10.1093/ofid/ofy119. eCollection 2018 Jun 1.

12.

Multifaceted but Invisible: Perceptions of the Value of a Pediatric Cognitive Specialty.

Szymczak JE, Lee G, Klieger SB, Woods C, Creech CB, Gilsdorf JR, Dennehy P, Zaoutis T.

Hosp Pediatr. 2018 Jul;8(7):385-393. doi: 10.1542/hpeds.2017-0240.

13.

Chronic Granulomatous Disease: Epidemiology, Pathophysiology, and Genetic Basis of Disease.

Rider NL, Jameson MB, Creech CB.

J Pediatric Infect Dis Soc. 2018 May 9;7(suppl_1):S2-S5. doi: 10.1093/jpids/piy008. Review.

14.

Methicillin-Resistant Staphylococcus aureus in a Trauma Population: Does Decolonization Prevent Infection?

Maxwell RA, Croft CA, Creech CB, Thomsen I, Soper N, Brown LE, Mejia VA, Dart BW 4th, Barker DE.

Am Surg. 2017 Dec 1;83(12):1407-1412.

PMID:
29336763
15.

Diffuse Papulovesicular Rash in an Infant With Eczema.

Riemenschneider K, Creech CB, Thomsen I.

J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):403-405. doi: 10.1093/jpids/pix032. No abstract available.

PMID:
29186591
16.

Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH).

Wood JB, Jones LS, Soper NR, Nagarsheth M, Creech CB, Thomsen IP.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00968-17. doi: 10.1128/AAC.00968-17. Print 2017 Nov.

17.

A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.

Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF; DMID 07-0051 Team.

N Engl J Med. 2017 Jun 29;376(26):2545-2555. doi: 10.1056/NEJMoa1607033.

18.

Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccination.

Galassie AC, Goll JB, Samir P, Jensen TL, Hoek KL, Howard LM, Allos TM, Niu X, Gordy LE, Creech CB, Hill H, Joyce S, Edwards KM, Link AJ.

Proteomics. 2017 Jun;17(12). doi: 10.1002/pmic.201600453.

19.

Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.

Thomsen IP, Sapparapu G, James DBA, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE Jr.

J Infect Dis. 2017 Apr 1;215(7):1124-1131. doi: 10.1093/infdis/jix071.

20.

Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.

Howard LM, Hoek KL, Goll JB, Samir P, Galassie A, Allos TM, Niu X, Gordy LE, Creech CB, Prasad N, Jensen TL, Hill H, Levy SE, Joyce S, Link AJ, Edwards KM.

PLoS One. 2017 Jan 18;12(1):e0167488. doi: 10.1371/journal.pone.0167488. eCollection 2017.

21.

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.

Frenck RW Jr, Creech CB, Sheldon EA, Seiden DJ, Kankam MK, Baber J, Zito E, Hubler R, Eiden J, Severs JM, Sebastian S, Nanra J, Jansen KU, Gruber WC, Anderson AS, Girgenti D.

Vaccine. 2017 Jan 5;35(2):375-384. doi: 10.1016/j.vaccine.2016.11.010. Epub 2016 Dec 1.

22.

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.

Creech CB, Frenck RW Jr, Sheldon EA, Seiden DJ, Kankam MK, Zito ET, Girgenti D, Severs JM, Immermann FW, McNeil LK, Cooper D, Jansen KU, Gruber W, Eiden J, Anderson AS, Baber J.

Vaccine. 2017 Jan 5;35(2):385-394. doi: 10.1016/j.vaccine.2016.11.032. Epub 2016 Nov 17.

23.

Best Practices for Treatment of Invasive Methicillin-Susceptible Staphylococcus aureus Infections: The Case for Oxacillin.

Wood JB, Thomsen IP, Creech CB, Newland JG.

J Pediatric Infect Dis Soc. 2016 Dec;5(4):480-482. Epub 2016 Sep 7. No abstract available.

PMID:
27609072
24.

Association Between Contact Sports and Colonization with Staphylococcus aureus in a Prospective Cohort of Collegiate Athletes.

Jiménez-Truque N, Saye EJ, Soper N, Saville BR, Thomsen I, Edwards KM, Creech CB.

Sports Med. 2017 May;47(5):1011-1019. doi: 10.1007/s40279-016-0618-6.

25.

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination.

Hoft DF, Lottenbach K, Goll JB, Hill H, Winokur PL, Patel SM, Brady RC, Chen WH, Edwards K, Creech CB, Frey SE, Blevins TP, Salomon R, Belshe RB.

J Infect Dis. 2016 Oct 1;214(7):1020-9. doi: 10.1093/infdis/jiw310. Epub 2016 Jul 20.

26.

Longitudinal Assessment of Colonization With Staphylococcus aureus in Healthy Collegiate Athletes.

Jiménez-Truque N, Saye EJ, Soper N, Saville BR, Thomsen I, Edwards KM, Creech CB.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):105-13. doi: 10.1093/jpids/piu108. Epub 2014 Nov 5.

27.

A Comprehensive Approach to the Management of Children and Adults with Chronic Granulomatous Disease.

Thomsen IP, Smith MA, Holland SM, Creech CB.

J Allergy Clin Immunol Pract. 2016 Nov - Dec;4(6):1082-1088. doi: 10.1016/j.jaip.2016.03.021. Epub 2016 May 10. Review.

PMID:
27178966
28.

Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy.

Carlucci JG, Halasa N, Creech CB, Dulek DE, Gómez-Duarte OG, Nelson GE, Talbot HK, Scalise ML, Scott PL, Mahadevan U, Beaulieu DB.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):e9-e12. doi: 10.1093/jpids/piw001. Epub 2016 Mar 24.

29.

H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.

Thornburg NJ, Zhang H, Bangaru S, Sapparapu G, Kose N, Lampley RM, Bombardi RG, Yu Y, Graham S, Branchizio A, Yoder SM, Rock MT, Creech CB, Edwards KM, Lee D, Li S, Wilson IA, García-Sastre A, Albrecht RA, Crowe JE Jr.

J Clin Invest. 2016 Apr 1;126(4):1482-94. doi: 10.1172/JCI85317. Epub 2016 Mar 7.

30.

Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis.

Chadha AD, Thomsen IP, Jimenez-Truque N, Soper NR, Jones LS, Sokolow AG, Torres VJ, Creech CB.

J Cyst Fibros. 2016 Sep;15(5):597-604. doi: 10.1016/j.jcf.2015.12.023. Epub 2016 Jan 25.

31.

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.

Mbawuike IN, Atmar RL, Patel SM, Corry DB, Winokur PL, Brady RC, Chen WH, Edwards KM, Creech CB, Walter EB Jr, Frey SE, Belshe RB, Goll JB, Hill H, Keitel WA.

Vaccine. 2016 Jan 20;34(4):547-554. doi: 10.1016/j.vaccine.2015.11.055. Epub 2015 Dec 4.

32.

Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant.

Chen WH, Jackson LA, Edwards KM, Keitel WA, Hill H, Noah DL, Creech CB, Patel SM, Mangal B, Kotloff KL.

Clin Vaccine Immunol. 2015 Nov 11;23(1):73-7. doi: 10.1128/CVI.00475-15. Print 2016 Jan.

33.

Prevention of Recurrent Staphylococcal Skin Infections.

Creech CB, Al-Zubeidi DN, Fritz SA.

Infect Dis Clin North Am. 2015 Sep;29(3):429-64. doi: 10.1016/j.idc.2015.05.007. Review.

34.

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial.

Jackson LA, Campbell JD, Frey SE, Edwards KM, Keitel WA, Kotloff KL, Berry AA, Graham I, Atmar RL, Creech CB, Thomsen IP, Patel SM, Gutierrez AF, Anderson EL, El Sahly HM, Hill H, Noah DL, Bellamy AR.

JAMA. 2015 Jul 21;314(3):237-46. doi: 10.1001/jama.2015.7916.

PMID:
26197184
35.

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects.

Frey SE, Wald A, Edupuganti S, Jackson LA, Stapleton JT, El Sahly H, El-Kamary SS, Edwards K, Keyserling H, Winokur P, Keitel W, Hill H, Goll JB, Anderson EL, Graham IL, Johnston C, Mulligan M, Rouphael N, Atmar R, Patel S, Chen W, Kotloff K, Creech CB, Chaplin P, Belshe RB.

Vaccine. 2015 Sep 22;33(39):5225-34. doi: 10.1016/j.vaccine.2015.06.075. Epub 2015 Jul 2.

PMID:
26143613
36.

Genome-Wide Association Study of Serum Creatinine Levels during Vancomycin Therapy.

Van Driest SL, McGregor TL, Velez Edwards DR, Saville BR, Kitchner TE, Hebbring SJ, Brilliant M, Jouni H, Kullo IJ, Creech CB, Kannankeril PJ, Vear SI, Brothers KB, Bowton EA, Shaffer CM, Patel N, Delaney JT, Bradford Y, Wilson S, Olson LM, Crawford DC, Potts AL, Ho RH, Roden DM, Denny JC.

PLoS One. 2015 Jun 1;10(6):e0127791. doi: 10.1371/journal.pone.0127791. eCollection 2015.

37.

Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.

Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, Pettibone S, Hoagland RJ, Chambers HF; DMID 07-0051 Team.

N Engl J Med. 2015 Mar 19;372(12):1093-103. doi: 10.1056/NEJMoa1403789.

38.

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant.

Chen WH, Jackson LA, Edwards KM, Keitel WA, Hill H, Noah DL, Creech CB, Patel SM, Mangal B, Kotloff KL.

Open Forum Infect Dis. 2014 Oct 8;1(3):ofu091. doi: 10.1093/ofid/ofu091. eCollection 2014 Dec.

39.

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

Winokur PL, Patel SM, Brady R, Chen WH, El-Kamary SS, Edwards K, Creech CB, Frey S, Keitel WA, Belshe R, Walter E, Bellamy A, Hill H.

J Infect Dis. 2015 Aug 15;212(4):525-30. doi: 10.1093/infdis/jiv087. Epub 2015 Feb 23.

40.

What we don't know might hurt us.

Creech CB, Edwards KM.

Lancet Infect Dis. 2015 Feb;15(2):133-5. doi: 10.1016/S1473-3099(14)71083-7. Epub 2015 Jan 8. No abstract available.

PMID:
25577660
41.

Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus among skin and soft tissue infections in an emergency department in Guyana.

Dozois A, Thomsen I, Jimenez-Truque N, Soper N, Pearson A, Mohamed-Rambaran P, Dettorre KB, Creech CB, Wright SW.

Emerg Med J. 2015 Oct;32(10):800-3. doi: 10.1136/emermed-2013-203373. Epub 2014 Dec 31.

PMID:
25552545
42.

Inter- and intraspecies metabolite exchange promotes virulence of antibiotic-resistant Staphylococcus aureus.

Hammer ND, Cassat JE, Noto MJ, Lojek LJ, Chadha AD, Schmitz JE, Creech CB, Skaar EP.

Cell Host Microbe. 2014 Oct 8;16(4):531-7. doi: 10.1016/j.chom.2014.09.002.

43.

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial.

Belshe RB, Frey SE, Graham IL, Anderson EL, Jackson LA, Spearman P, Edupuganti S, Mulligan MJ, Rouphael N, Winokur P, Dolor RJ, Woods CW, Walter EB, Chen WH, Turley C, Edwards KM, Creech CB, Hill H, Bellamy AR; National Institute of Allergy and Infectious Diseases–Funded Vaccine and Treatment Evaluation Units.

JAMA. 2014 Oct 8;312(14):1420-8. doi: 10.1001/jama.2014.12609.

PMID:
25291578
44.

Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.

Kotloff KL, Halasa NB, Harrison CJ, Englund JA, Walter EB, King JC, Creech CB, Healy SA, Dolor RJ, Stephens I, Edwards KM, Noah DL, Hill H, Wolff M.

Pediatr Infect Dis J. 2014 Aug;33(8):865-71. doi: 10.1097/INF.0000000000000329.

45.

Novel risk factors for recurrent Clostridium difficile infection in children.

Nicholson MR, Thomsen IP, Slaughter JC, Creech CB, Edwards KM.

J Pediatr Gastroenterol Nutr. 2015 Jan;60(1):18-22. doi: 10.1097/MPG.0000000000000553.

46.

Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Costa Rican children.

Jimenez-Truque N, Saye EJ, Thomsen I, Herrera ML, Creech CB.

Pediatr Infect Dis J. 2014 Jul;33(7):e180-2. doi: 10.1097/INF.0000000000000291.

47.

Evaluation of the feasibility of a state-based vaccine safety advice network.

Williams SE, Vellozzi C, Edwards KM, Moore KL, Sharma D, Creech CB.

Vaccine. 2014 Feb 12;32(8):901-3. doi: 10.1016/j.vaccine.2013.12.062. Epub 2014 Jan 9.

PMID:
24412301
48.

Children with invasive Staphylococcus aureus disease exhibit a potently neutralizing antibody response to the cytotoxin LukAB.

Thomsen IP, Dumont AL, James DB, Yoong P, Saville BR, Soper N, Torres VJ, Creech CB.

Infect Immun. 2014 Mar;82(3):1234-42. doi: 10.1128/IAI.01558-13. Epub 2013 Dec 30.

49.

Frequency of disinfectant resistance genes in pediatric strains of methicillin-resistant Staphylococcus aureus.

Johnson JG, Saye EJ, Jimenez-Truque N, Soper N, Thomsen I, Talbot TR, Creech CB.

Infect Control Hosp Epidemiol. 2013 Dec;34(12):1326-7. doi: 10.1086/673983. Epub 2013 Oct 28. No abstract available.

50.

Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults.

Creech CB, Dekker CL, Ho D, Phillips S, Mackey S, Murray-Krezan C, Grazia Pau M, Hendriks J, Brown V, Dally LG, Versteege I, Edwards KM.

Hum Vaccin Immunother. 2013 Dec;9(12):2548-57. doi: 10.4161/hv.26038. Epub 2013 Aug 17.

Supplemental Content

Loading ...
Support Center